SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Diversa Corporation (DVSA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg S. who started this subject7/19/2004 7:41:57 AM
From: nigel bates   of 144
 
Diversa Signs Agreement With GlaxoSmithKline to Advance Development of a Novel Anti-Infective Compound

SAN DIEGO, July 19 /PRNewswire-FirstCall/ -- Diversa Corporation (Nasdaq: DVSA - News) today announced that it has signed an agreement with GlaxoSmithKline to advance the development of an anti-infective compound initially discovered by GSK. This agreement represents an innovative approach to leverage and integrate core capabilities in process development and drug development of the respective companies to advance a novel anti-infective compound.

Under the terms of this agreement, Diversa will have the primary responsibility to develop the chemistry processes required to advance the compound into clinical development. Upon achievement of specific performance criteria by Diversa, GSK will have the option to further develop this compound and obtain exclusive worldwide commercialization rights in exchange for milestone payments, option and license fees, and royalties to Diversa. If GSK decides not to exercise this option, then Diversa will obtain development and commercialization rights to the compound in exchange for royalties to GSK.

"We look forward to working on this important anti-infective compound, which is complementary with our anti-infective focus and our strategy of pursuing therapeutics to treat serious, hospital-based infections," said Dr. Jay M. Short, Diversa's President and Chief Executive Officer...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News